Highlights Novo Nordisk A/S

Equities

NOVO B

DK0062498333

Pharmaceuticals

Market Closed - Nasdaq Copenhagen Other stock markets 01:20:00 16/04/26 am AEST			5-day change	1st Jan Change
251.85 ^DKK	+2.32%		+4.89%	-22.57%

15/04	GoodRx Offering Novo Nordisk's Wegovy HD Weight Loss Drug	MT
15/04	SB1 Markets Starts Novo Nordisk Coverage at Buy	MT

Highlights

15/04	GoodRx Offering Novo Nordisk's Wegovy HD Weight Loss Drug	MT
15/04	European shares flat as investors weigh corporate earnings; Middle East in focus	RE
15/04	Novo Nordisk A/S and OpenAI Partner to Transform How Medicines Are Discovered and Delivered	CI
15/04	FDA seeks additional safety data from Lilly on newly approved weight-loss pill	RE
14/04	Exchange-Traded Funds, Equity Futures Lower Pre-Bell Tuesday Amid Hopes of Long-Term US-Iran Truce	MT
14/04	S&P 500 Rebound, Optimism for US-Iran Deal Move US Equity Futures Higher Pre-Bell	MT
14/04	Betting on Restraint
14/04	Novo Nordisk Receives UK Regulator Approval for Single-Dose 7.2mg of Wegovy	MT
14/04	European Midday Briefing : Shares Rise, Oil Slips on Peace Talks Hopes	DJ
14/04	Novo Nordisk Partners with OpenAI to Boost Drug Development, Delivery	MT
10/04	Wall Street Gets a CPI Lifeline
10/04	Lifemd Inc Announces Foundayo Orforglipron Oral Glp-1 Pill for Weight Management	CI
09/04	Novo Nordisk Says EU Regulator Approves Updated Wegovy Injection	MT
09/04	Novo Nordisk's Updated Product Storage for Wegovy Injection Gets EU Approval	MT
09/04	Ema approves Novo Nordisk's Wegovy injection for 48 hours controlled-temperature delivery	RE
09/04	Novo Nordisk A/S Receives Ema Approval for Controlled-Temperature Delivery of Wegovy Injection in Europe	CI
08/04	Lexaria Bioscience Corp Recognizes Eli Lilly and Company Foundayo Drug Approval	CI
07/04	Novo Nordisk Launches Higher Dose Wegovy in US With Pricing Below Eli Lilly's Zepbound	MT
07/04	Health Care Down on Earnings Doubts -- Health Care Roundup	DJ
03/04	Novo Nordisk Demonstrates Greater Weight Loss with Wegovy Pill Compared to Orforglipron	CI
02/04	Wall Street sees multi-billion dollar debut for Lilly's obesity pill despite Novo lead	RE
02/04	US Set to Impose 100% Tariffs on Some Drug Imports	MT
02/04	Pricing and availability of Novo, Lilly's weight-loss drugs	RE
02/04	Lilly gains after FDA approves weight-loss pill, sizing down investor doubts	RE
02/04	INSTANT VIEW-Lilly gets FDA nod for oral obesity pill, analysts see strong uptake potential	RE